Literature DB >> 16935749

Exploiting the enhanced permeability and retention effect for tumor targeting.

Arun K Iyer1, Greish Khaled, Jun Fang, Hiroshi Maeda.   

Abstract

Of the tumor targeting strategies, the enhanced permeability and retention (EPR) effect of macromolecules is a key mechanism for solid tumor targeting, and considered a gold standard for novel drug design. In this review, we discuss various endogenous factors that can positively impact the EPR effect in tumor tissues. Further, we discuss ways to augment the EPR effect by use of exogenous agents, as well as practical methods available in the clinical setting. Some innovative examples developed by researchers to combat cancer by the EPR mechanism are also discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935749     DOI: 10.1016/j.drudis.2006.07.005

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  384 in total

1.  In vivo fluorescence imaging in the second near-infrared window with long circulating carbon nanotubes capable of ultrahigh tumor uptake.

Authors:  Joshua T Robinson; Guosong Hong; Yongye Liang; Bo Zhang; Omar K Yaghi; Hongjie Dai
Journal:  J Am Chem Soc       Date:  2012-06-15       Impact factor: 15.419

2.  Noninvasive detection of passively targeted poly(ethylene glycol) nanocarriers in tumors.

Authors:  Yashveer Singh; Dayuan Gao; Zichao Gu; Shike Li; Stanley Stein; Patrick J Sinko
Journal:  Mol Pharm       Date:  2011-11-22       Impact factor: 4.939

3.  Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions.

Authors:  Natalya Rapoport; Kweon-Ho Nam; Roohi Gupta; Zhongao Gao; Praveena Mohan; Allison Payne; Nick Todd; Xin Liu; Taeho Kim; Jill Shea; Courtney Scaife; Dennis L Parker; Eun-Kee Jeong; Anne M Kennedy
Journal:  J Control Release       Date:  2011-01-26       Impact factor: 9.776

4.  Chemically self-assembled antibody nanorings (CSANs): design and characterization of an anti-CD3 IgM biomimetic.

Authors:  Qing Li; Christopher R So; Adrian Fegan; Vivian Cody; Mehmet Sarikaya; Daniel A Vallera; Carston R Wagner
Journal:  J Am Chem Soc       Date:  2010-11-15       Impact factor: 15.419

Review 5.  Inorganic nanoparticle-based contrast agents for molecular imaging.

Authors:  Eun Chul Cho; Charles Glaus; Jingyi Chen; Michael J Welch; Younan Xia
Journal:  Trends Mol Med       Date:  2010-11-10       Impact factor: 11.951

Review 6.  Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.

Authors:  Andrew B Hill; Mingfu Chen; Chih-Kuang Chen; Blaine A Pfeifer; Charles H Jones
Journal:  Trends Biotechnol       Date:  2015-12-23       Impact factor: 19.536

7.  Accumulation of nano-sized particles in a murine model of angiogenesis.

Authors:  Thomas R Wittenborn; Esben K U Larsen; Thomas Nielsen; Louise M Rydtoft; Line Hansen; Jens V Nygaard; Thomas Vorup-Jensen; Jørgen Kjems; Michael R Horsman; Niels Chr Nielsen
Journal:  Biochem Biophys Res Commun       Date:  2013-12-07       Impact factor: 3.575

Review 8.  RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.

Authors:  Eunice L Lozada-Delgado; Nilmary Grafals-Ruiz; Pablo E Vivas-Mejía
Journal:  Life Sci       Date:  2017-08-31       Impact factor: 5.037

9.  Cytoplasmic delivery of liposomal contents mediated by an acid-labile cholesterol-vinyl ether-PEG conjugate.

Authors:  Jeremy A Boomer; Marquita M Qualls; H Dorota Inerowicz; Robert H Haynes; V Srilakshmi Patri; Jong-Mok Kim; David H Thompson
Journal:  Bioconjug Chem       Date:  2009-01       Impact factor: 4.774

Review 10.  A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy.

Authors:  Samaresh Sau; Katyayani Tatiparti; Hashem O Alsaab; Sushil K Kashaw; Arun K Iyer
Journal:  Drug Discov Today       Date:  2018-03-15       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.